Replies to post #15841 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

I'll "Handicap" this and say that once another [40mg Copaxone] entry gets approval…the floor will drop out.

Your prediction is not especially meaningful without a time specification.

If you want to dispute my numbers in #msg-124749893, that’s what message boards are for—but you should have the gumption to post your own numbers.